Noncompaction cardiomyopathy genetic testing: Difference between revisions
Jump to navigation
Jump to search
(New page: {{Noncompaction cardiomyopathy}} {{CMG}} ==Overview== Genetic testing can be of use in counseling family members. 40% of family members will be affected.) |
|||
| (3 intermediate revisions by the same user not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Genetic testing can be of use in counseling family members. | Genetic testing can be of use in counseling family members. | ||
==Demographics and Epidemiology== | |||
40% of family members will be affected. | |||
==Diagnosis== | |||
===Specific Genes to Test For=== | |||
Known mutations should be tested for. Examples include the following: | |||
*One defect is in the gene that encodes for [[alpha-dystrobrevin]]. This is a [[dystrophin-associated protein]] which has been mapped to [[chromosome 18q12]]. The role of this protein is to preserve the structural integrity of the muscle membrane. | |||
*There is a second X-linked genetic defect which involves a mutation in the gene G4.5 (TAZ), the same gene involved in [[Barth syndrome]]. As a result, some patients with NCC have features of [[Barth syndrome]]. This gene which encodes for [[tafazzin]]. | |||
* Mutations of the [[ryanodine receptor 2 gene]] ([[RyR2]]) as has been seen in patients with [[arrhythmogenic right ventircular dysplasia]]. | |||
* Deletions of the [[FKBP12 gene]] result in noncompaction in the mouse. | |||
* [[LMNA]] mutations | |||
*Abnormalities of trnascription factors such as NKX2.5 and TBX5. | |||
*Abnormalities of 11p15 as suggested in a GWAS analysis. | |||
*22q11 deletion | |||
The majority of the time the pattern of inheritance is [[autosomal dominant]]. In some families, the mode of transmission appears to be x-linked or via mitochondrial transmission. | |||
==References== | |||
{{Reflist|2}} | |||
[[Category:Cardiology]] | |||
[[Category:Template complete]] | |||
[[Category:Overview complete]] | |||
[[Category:Genetic disorders]] | |||
Latest revision as of 11:07, 6 August 2011
|
Noncompaction Cardiomyopathy Microchapters |
|
Pathophysiology |
|---|
|
Differentiating Noncompaction Cardiomyopathy from other Diseases |
|
Diagnosis |
|
Treatment |
|
Noncompaction cardiomyopathy genetic testing On the Web |
|
Risk calculators and risk factors for Noncompaction cardiomyopathy genetic testing |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Genetic testing can be of use in counseling family members.
Demographics and Epidemiology
40% of family members will be affected.
Diagnosis
Specific Genes to Test For
Known mutations should be tested for. Examples include the following:
- One defect is in the gene that encodes for alpha-dystrobrevin. This is a dystrophin-associated protein which has been mapped to chromosome 18q12. The role of this protein is to preserve the structural integrity of the muscle membrane.
- There is a second X-linked genetic defect which involves a mutation in the gene G4.5 (TAZ), the same gene involved in Barth syndrome. As a result, some patients with NCC have features of Barth syndrome. This gene which encodes for tafazzin.
- Mutations of the ryanodine receptor 2 gene (RyR2) as has been seen in patients with arrhythmogenic right ventircular dysplasia.
- Deletions of the FKBP12 gene result in noncompaction in the mouse.
- LMNA mutations
- Abnormalities of trnascription factors such as NKX2.5 and TBX5.
- Abnormalities of 11p15 as suggested in a GWAS analysis.
- 22q11 deletion
The majority of the time the pattern of inheritance is autosomal dominant. In some families, the mode of transmission appears to be x-linked or via mitochondrial transmission.